4//SEC Filing
ADELMAN DANIEL C MD 4
Accession 0000899243-20-012850
CIK 0001631650other
Filed
May 11, 8:00 PM ET
Accepted
May 12, 5:15 PM ET
Size
6.2 KB
Accession
0000899243-20-012850
Insider Transaction Report
Form 4
ADELMAN DANIEL C MD
Chief Medical Officer
Transactions
- Award
Common Stock, $0.0001 par value
2020-05-10+2,420→ 29,715 total
Footnotes (4)
- [F1]These shares represent restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest as to 100% of the underlying shares on September 11, 2020 (the "Vesting Date"), subject to the Reporting Person's continued service relationship with the Issuer on the Vesting Date.
- [F2]Includes 8,750 RSUs and will be settled in common stock upon vesting. The RSUs vest in three successive, equal, annual installments measured from March 1, 2020, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F3]Includes 8,906 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2019, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F4]Includes 7,031 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2018, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
Related Parties
1- filerCIK 0001222037
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 5:15 PM ET
- Size
- 6.2 KB